US 10,022,319 · Application 13/522,848 · Granted Jul 17, 2018
US 10,022,319
Stabilized antibody-containing liquid formulations
Estimated expiration
September 5, 2031
4y 358d remaining
- Could not fetch continuity data for application PCTJP2011050911: Resource not found (404)
Earliest effective filing
Jan 20, 2011
+ 20 years
Jan 20, 2031
PTA +228d
Sep 5, 2031
No TD
—
Final
Sep 5, 2031
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- October 2, 2012
- Earliest effective filing
- January 20, 2011
- Issue date
- July 17, 2018
- PTA
- +228 days
- Base expiry (before PTA)
- January 20, 2031
January 20, 2011 + 20 years = January 20, 2031 + 228 PTA days = September 5, 2031
- National stage entry of application PCTJP2011050911, filed Jan 20, 2011
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/522,848 · US 10,022,319
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 10,022,319: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US10022319Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.